Cardiovascular Devices Global Market Report 2022

Cardiovascular Devices Global Market Report 2022

  • May 2022 •
  • 250 pages •
  • Report ID: 6277147 •
  • Format: PDF
Major companies in the cardiovascular devices market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc., and Becton Dickinson.

The global cardiovascular devices market is expected to grow from $53.44 billion in 2021 to $59.48 billion in 2022 at a compound annual growth rate (CAGR) of 11.3%. The market is expected to grow to $85.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%.

The cardiovascular devices market consists of sales of cardiovascular devices and related services by entities (organizations, sole traders, and partnerships) that produce cardiovascular devices used in diagnosing and treating cardiovascular diseases.

The main types in the cardiovascular devices market are cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, and cardiac assist devices and equipment.Defibrillators are devices that are restoring the normal heartbeat by sending an electric pulse or shock to the heart.

They are used to prevent or correct an arrhythmia, a heartbeat that is uneven or slow or fast.The type of expenditure is public, private.

The products used are instruments/equipment, disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others.

North America was the largest region in the global cardiovascular devices market in 2021.Western Europe was the second largest region in the global cardiovascular devices market.

Africa. was the smallest region in the global cardiovascular devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Leadless pacemakers are being used for certain medical conditions such as slow heart rate (bradycardia), as they provide a less-invasive alternative to conventional pacemakers.A leadless pacemaker is a self-contained device that is inserted in the right ventricle of the heart without incisional access, leads, or a surgical pocket.

Furthermore, the medical procedure for a leadless pacemaker can be performed in under 30 minutes, with few postprocedural restrictions.These devices are gaining popularity as they eliminate complications related to lead placement which includes cardiac perforation, pneumothorax, and lead dislodgement.

Major companies manufacturing leadless pacemakers are Medtronic and Abbott.

The countries covered in the cardiovascular devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam.